MET and neoplasm: In cancer, CHROMR binds additional miRNAs (e.g., miR-27b-3p, miR-186-5p, miR-1299) that repress cell cycle regulators such as CNNM1, MET, and NCAPG2, thereby promoting tumor proliferation and metastasis.